GTC BIOTHERAPEUTICS
USPTO Trademark Record · Serial No. 78117241
Trademark details
It was initially claimed by LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES, S.A. on 20020325.
That brand applies to the following goods and services:[ Pharmaceutical preparations and vaccines for the treatment of myocardial infarction, cancer, multiple sclerosis, stroke, sepsis, heredity deficiency of the molecule leading to increased thrombolytic events, and heparin resistance in medical procedures; biologics; cells, cell lines and cell cultures for medical and clinical use in the production of proteins for therapeutic and diagnostic use; ] proteins [ and cloned DNA ] from [ humans, plants, ] animals [, bacteria and other micro-organisms ], [ Custom manufacture of transgenic animal products, namely, pharmaceuticals, biopharmaceuticals and proteins ], [ Providing technical advice, research, testing and analysis in the field of pharmaceutical drug development; pharmaceutical drug development ].
Currently that trademark is represented by trademark attorney(s): Cynthia Johnson Walden.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the GTC BIOTHERAPEUTICS trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
